FDA adds warning to baricitinib label: hypersensitivity

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1814卷 / 1期

关键词：

D O I：

10.1007/s40278-020-80990-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] FDA adds "black box" warning to fluoroquinolone antibiotics
Tanne, Janice Hopkins
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7662):
[2] Testosterone: FDA adds warning about VTE risk
Reactions Weekly, 2014, 1508 (1) : 3 - 3
[3] FDA adds Boxed Warning on risk of death with febuxostat
Reactions Weekly, 2019, 1742 (1) : 1 - 1
[4] FDA lifts olestra warning label
Walsh, K
CHEMICAL WEEK, 2003, 165 (28) : 42 - 42
[5] No FDA warning label for doxazosin as yet
Reactions Weekly, 2001, 856 (1) : 2 - 2
[6] US FDA adds pharmacogenetic information to Plavix® label
不详
PHARMACOGENOMICS, 2009, 10 (08) : 1218 - 1218
[7] FDA GROUP URGES SUX LABEL REDUCED TO WARNING
MORELL, RC
JOURNAL OF CLINICAL MONITORING, 1995, 11 (02): : 141 - 143
[8] Drug maker found liable despite FDA warning label
Nature, 2009, 458 (7235) : 137 - 137
[9] Eli Lilly adds bolded warning on atomoxetine label about liver safety
不详
CNS SPECTRUMS, 2005, 10 (02) : 82 - 82
[10] Examination of Voluntary Compliance with New FDA Cigar Warning Label Requirements
Wackowski, Olivia A.
Kurti, Marin
Schroth, Kevin R. J.
Delnevo, Cristine D.
TOBACCO REGULATORY SCIENCE, 2020, 6 (06) : 379 - 383

← 1 2 3 4 5 →